Filing status
- Accounts due
- 31 January 2027
- Last accounts
- 31 January 2025
- Conf. stmt due
- 27 January 2027
- Last conf. stmt
- 13 January 2026
Edinburgh Molecular Imaging Limited
- Incorporated
- 13 January 2014 (12 years)
- Industry
- Research and experimental development on biotechnology (72110) Other research and experimental development on natural sciences and engineering (72190)
- Owned by
- Accounts type
- Total exemption full
- Region
- Scotland
- Address
- 137A George StreetEdinburghEH2 4JY
Charges
- Total
- 6
- Outstanding
- 5
- Part satisfied
- 0
- Satisfied
- 1
Officers
Not loaded yet. See them on Companies House
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 25–50% of shares
Holds 25–50% of voting rights
Limited Partnership
Reg. no. Sl11942
Group structure 11 companies
Ownership group derived from the Companies House PSC register
Eli Lilly and Company Limited Owns 75–100% of shares
Eli Lilly Holding Company Limited Owns 75–100% of shares
Eli Lilly Leasing Limited Owns 75–100% of shares
Epidarex Capital II, LP Part right to 25–50% of surplus assets
Edinburgh Molecular Imaging Limited This company Owns 25–50% of shares
Greenfield Pharmaceuticals Limited Owns 75–100% of shares
Lilly Industries Limited Owns 75–100% of shares
Lilly Research Centre Limited Owns 75–100% of shares
Eli Lilly Group Pension Trustees Limited Owns 75–100% of shares
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Edinburgh
Cambridge
Cambridge
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →